Page 3 - Balance Sheet Data News Today : Breaking News, Live Updates & Top Stories | Vimarsana

First quarter revenue of $1,358 million increased 15% year-over-year, led by international growth of 21%First quarter operating income of $233 million increased 26% year-over-yearFirst quarter net income of $112 million, an 8.2% margin, increased 56% year-over-yearFirst quarter adjusted EBITDA* of $336 million, a 24.7% margin and the highest in over 15 years, increased 25% and 206 basis points year-over-yearCash provided by operating activities of $131 million, and adjusted free cash flow* of $8

First Quarter 2024 Highlights Versus Prior Year Net Sales of $810 million, down 1% as reported and in constant currency Gross Margin of 48.0%, an increase of 800 basis points; Adjusted Gross...

First quarter revenue of $1,358 million increased 15% year-over-year, led by international growth of 21%First quarter operating income of $233 million increased 26% year-over-yearFirst quarter net...

First quarter revenue of $1,358 million increased 15% year-over-year, led by international growth of 21%First quarter operating income of $233 million...

Data from novel proprietary neurotropic adeno-associated virus delivery capsid, STAC-BBB, demonstrated industry-leading blood-brain barrier penetration in non-human primates following intravenous...